Skip to content
Home » IRB

IRB

COVID vaccine development process – how it compares to “normal”

The development process for COVID-19 vaccines was accelerated yet robust and thorough, maintaining rigorous safety and effectiveness standards. Efforts to speed up the process included enrolling over 100,000 patients worldwide, fast-tracking data analysis and regulatory reviews, and preparing manufacturing facilities. Despite the rapid pace, multiple independent agencies and expert groups ensured vaccine safety and effectiveness, making it nearly impossible for a harmful vaccine to reach the market. This process, vital in saving lives amidst the pandemic, still follow established protocols used in pre-pandemic vaccine development.